BIIB - バイオジェン （Biogen Inc.）

CAMBRIDGE, Mass., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period of the new drug application (NDA) for tofersen by three months. Tofersen is an investigational treatment for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS). The updated Prescription Drug User Fee Act (PDUFA) goal date is April 25, 2023.

Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) today presented additional data from the Phase 3 SKYLARK Study of zuranolone in adult women with postpartum depression (PPD), at the 35th European College of Neuropsychopharmacology (ECNP) Congress, taking place October 15-18, 2022, in Vienna, Austria. This was the first time the SKYLARK Study was presented at a medical congress.

Interest in the readout on gantenerumab has heightened since drugmakers Eisai and Biogen announced positive results for lecanemab.

The post How Biogen Makes Money In 2022 And How They Defied Gravity appeared on BitcoinEthereumNews.com . | Getty Images Key Takeaways Biogen has seen its stock price skyrocket after groundbreaking news about its new Alzheimer’s treatment that could improve the lives of millions of Americans, and…

INMD rose on preliminary results. DPZ climbed on earnings news. PGR dipped after publishing monthly performance figures. BIIB rose on an analyst upgrade.

Robert W. Baird Stick to Their Hold Rating for Biogen

Related Stocks: BDX , BIV , AGG , IXN , SNV , FB , ATO , PZA , PRU , MUB , RHI , NVDA , SCHW , CCBG , T , LLY , PPG , FDN , VFC , IHI , BIIB , VOD , NNN ,

Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) today announced new data from the LANDSCAPE and NEST clinical development progra

Biogen''s Aduhelm (aducanumab) injections get governemnt go-ahead

Gayle Smith, head of global Covid-19 response at the State Department, urged U.S. vaccine makers to back low-cost manufacturing hubs overseas.

Summary List Placement Hello, Welcome to Insider Healthcare. I''m Lydia Ramsey Pflanzer, and today in healthcare news: We found 9 players working behind the scenes who can make or break a digital health startup ; It''s back to wearing masks indoors, even for those fully vaccinated, CDC says ; Here''s the presentation Deep Genomics used to raise $180 million from investors including SoftBank and Khosla . If you''re new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125 . Let''s get to it As coronavirus cases continue to surge in the US fueled by the Delta variant, the CDC introduced new masking guidelines . Everyone should mask up indoors, whether vaccinated or not , in areas of the country at higher risk from the virus. The CDC also recommended that everyone in K-12 schools wear a mask indoors. CDC Director Rochelle Walensky said on Tuesday that new data about Delta had prompted the change from May, when the CDC had said that masks were no longer necessary for fully vaccinated people.

Adalimumab market report presents the best market and business solutions to Pharmaceutical industry in this rapidly revolutionizing market place to thrive in the market. Market definition gives the scope of particular product with respect to the driving factors and restraints